Buch, Englisch, 782 Seiten, Format (B × H): 159 mm x 241 mm, Gewicht: 1150 g
Buch, Englisch, 782 Seiten, Format (B × H): 159 mm x 241 mm, Gewicht: 1150 g
ISBN: 978-93-5696-730-4
Verlag: JP Medical
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
SECTION 1: CONTROVERSIES
CHAPTER 1: Introduction
CHAPTER 2: The Totality of Evidence
CHAPTER 3: COVID-19 Censorship in the European Union: The Example of Austria
CHAPTER 4: COVID-19, Hydroxychloroquine, Politics, and Scientific Author Political Party Donation History—What could Possibly Go Wrong?
CHAPTER 5: “You are not a Horse”: Medicalization, Social Control, and Academic Discourse in the COVID-19 Era
CHAPTER 6: Origin of COVID Pandemic: A Natural Calamity or Manmade Adventure
CHAPTER 7: Origins of COVID through the Indian Context
CHAPTER 8: Gain-of-function and Origin of COVID-19
CHAPTER 9: The Enigma of the 1889 Russian Flu Pandemic: A Coronavirus?
SECTION 2: NONPHARMACOLOGIC INTERVENTIONS
CHAPTER 10: The Use of Masks in the Prevention of SARS-CoV-2 Transmission
CHAPTER 11: Managing COVID-19 in Hong Kong: Lessons from SARS 2003 and Effective Strategies for Control
CHAPTER 12: COVID-19 and Dentistry
CHAPTER 13: The Evolving Role of Simulation in Surgical Training
CHAPTER 14: The Impact of the COVID-19 Pandemic on Nursing
CHAPTER 15: Immunology in COVID-19
CHAPTER 16: The Experience in the Making of COVID-19 Vaccines
CHAPTER 17: Controversies Concerning the Immunology of the COVID-19 Adaptive Immunity Vaccines
CHAPTER 18: The COVID-19 Vaccine
SECTION 3: SPECIAL ISSUE OF INTEREST
CHAPTER 19: The Art of Living
CHAPTER 20: Computed Tomography Thorax in COVID Management: A Rightfully Used or Misused Tool?
CHAPTER 21: Surgical Education and Training during the COVID-19 Pandemic
SECTION 4: THERAPIES
CHAPTER 22: The Need to Revisit Hydroxychloroquine in Early Treatment Strategies of COVID-19
CHAPTER 23: Ivermectin
CHAPTER 24: Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19
CHAPTER 25: Antivirals
CHAPTER 26: Glucocorticoids in Viral Pneumonia and COVID-19
CHAPTER 27: Therapeutic Effects of Fluvoxamine in the Management of COVID-19
CHAPTER 28: Randomized Placebo Controlled Trials in the COVID Era: A Question of Faith?
SECTION 5: COMPLICATIONS
CHAPTER 29: An Update on the Relationship between SARS-CoV-2 (COVID-19) and its Neurological Manifestations
CHAPTER 30: Myocarditis: COVID-19 and COVID-19 Vaccines
CHAPTER 31: Injuries from the SARS CoV-2 Vaccines
CHAPTER 32: Tracheostomy during COVID-19 Pandemic; To Do or Not To Do
CHAPTER 33: Telemedicine for Medical Students—Lessons Learnt from the Pandemic
CHAPTER 34: Censorship of the Biomedical Literature during the COVID-19 Era
